Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.

Matson et al. (2009) looked at every paper they could find on using psych meds for challenging behavior in people with intellectual disability. They did not run a new experiment. They simply read and summed up the old ones.

The review covered all types of psychotropics: antipsychotics, mood stabilizers, antidepressants, and drugs for attention. The goal was to see if any drug clearly helped reduce self-injury, aggression, or severe tantrums.

The authors found almost no solid proof that any psychotropic drug works for challenging behavior. A few small studies showed a blip of benefit, but most showed nothing at all.

They also noticed that many prescriptions were written without a clear diagnosis like schizophrenia or bipolar disorder. In short, people were getting heavy meds for behavior, not for mental illness.

Cudré-Mauroux (2010) came next and said the same thing, only louder: giving antipsychotics for aggression is often mistreatment because the behavior is rarely psychotic. The newer paper sharpened the warning.

Willner (2015) updated the search and still found no reliable benefit for any drug except maybe risperidone. That paper now supersedes the 2009 review by adding six more years of null results.

On the flip side, Rose et al. (2000) showed that a simple group anger-management class cut aggression for a full year in adults with ID. Their behavioral result gives clinicians a ready-made alternative to pills.

If you are writing a behavior plan, start with a functional assessment, not a pharmacy referral. The past twenty years of reviews agree: meds rarely beat placebo for hitting, biting, or screaming. Use the data to advocate for behavior supports, staff training, or environmental changes first. When a doctor suggests adding a drug, ask for the diagnosis that drug is meant to treat. If the answer is “for behavior,” show them these reviews and offer your behavior plan instead.